Mentges B, Brückner R, Weiss C
Klink und Poliklinik für Allgemein- und Abdominalchirurgie, Johannes Gutenberg Universität, Mainz.
Langenbecks Arch Chir. 1990;375(2):106-11. doi: 10.1007/BF00713395.
254 patients were operated for rectal carcinoma in the period from 1980 to 1986. The number of curative procedures, recurrence rate and 5-year-survival rate were dependent on the preoperative CEA levels, which correlated with the tumour stage. Even within tumour stages with enough cases for statistical evaluation the CEA could be established as an independent prognostical variable. Within stage pT2N0M0 recurrence rate for patients with preoperative CEA level below 5 ng/ml was 29% compared to 64% in patients with higher serum levels. Median survival time for the two groups were 65 and 35 months, respectively. In stage of lymph node involvement median survival times of 46 and 25 months were observed for the groups with CEA levels above and below 5 ng/ml. The pattern of recurrence within the two stages seemed to be unaffected by the preoperative CEA level. Patients with preoperative elevated CEA represent a risk group with need of consistent postoperative follow-up and CEA controls.
1980年至1986年期间,254例患者接受了直肠癌手术。根治性手术的数量、复发率和5年生存率取决于术前癌胚抗原(CEA)水平,而CEA水平与肿瘤分期相关。即使在有足够病例进行统计学评估的肿瘤分期内,CEA也可被确立为一个独立的预后变量。在pT2N0M0期,术前CEA水平低于5 ng/ml的患者复发率为29%,而血清水平较高的患者复发率为64%。两组的中位生存时间分别为65个月和35个月。在淋巴结受累阶段,CEA水平高于和低于5 ng/ml的两组患者的中位生存时间分别为46个月和25个月。两个阶段内的复发模式似乎不受术前CEA水平的影响。术前CEA升高的患者属于高危组,需要进行持续的术后随访和CEA监测。